D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon.
D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon .
Sharma told CNBC-Awaaz, "One can accumulate Biocon with a stoploss of Rs 229. The stock can touch level of Rs 255 in medium term."
The company touched its 52-week high Rs 382.00 and 52-week low Rs 225.75 on 20 Jul, 2011 and 27 Apr, 2012, respectively.
Set email alert for
ADS BY GOOGLE
video of the day
Why HSBC MF has a contrarian bet on IT stocks